Pharma sector to benefit from US business

Pharma sector to benefit from US business

Mumbai: Pharmaceutical companies are expected to deliver double digit revenue growth in the first quarter and large-cap stocks are expected to benefit from improved earnings from their US sales and low base effect, said brokerages in their preview for the sector. "This will be the third consecutive quarter with double-digit top line growth, aided by improved base businesses in the US and domestic business growth of 11 per cent year on year", HDFC Securities said.

Read more at 
Deccan Chronicle

Timeline

.......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
.......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........
.......... .......... .......... .......... ..........
  • .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... ..........

In-depth coverage

Read more top Business stories on Crisp